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HEALTH INSURANCE STATUS AND SEVERE MATERNAL MORBIDITY OUTCOMES IN THE UNITED
STATES - A POLICY REVIEW

by

ADEJUMOBI OTEKUNRIN, MD

Under the Direction of Colin K. Smith, DrPH

ABSTRACT
Objective: To show evidence of the relationship between insurance status, type, and duration
of coverage on severe maternal morbidity and mortality outcomes in the United States.
Methods: A review of multi-state and national studies was done to show the relationship
between insurance type on the incidence, timing, and outcome of severe maternal morbidities
(SMM). A retrospective cohort study from 2010-2014 used data from the IBM MarketScan
Multi-State Medicaid and Commercial Claims and Encounters databases to evaluate timing of
SMM during delivery hospitalization of 2,667,325 women aged 15-44 years. Women with SMM
were identified using the ICD-9-CM codes for 21 factors associated with SMM. Results from the
national Pregnancy Mortality Surveillance System (PMSS) for 2011-2015 was reviewed for
pregnancy-related deaths by sociodemographic characteristics, timing relative to end of
pregnancy, and the leading causes of death. Results from 13 state maternal mortality review
committees (MMRCs) from 2013-2017 on pregnancy-related deaths was reviewed for
predisposing factors and preventability.
Results: For the retrospective cohort study, a total of 2,399 women (73.5%) in the Medicaid
cohort and 3,993 women (75.7%) in the commercial insurance cohort with SMM after discharge
were diagnosed in the first 2 weeks after delivery hospitalization discharge. In the Medicaid
cohort, Black women had a higher likelihood (aOR, 1.69; 95% CI, 1.57-1.81) of SMM in the
postdelivery discharge period compared with White women. In the commercial insurance
cohort in the post-delivery discharge period, women residing in the southern region of the US
compared with women residing in the northeastern region had a higher likelihood of SMM
(aOR, 1.29; 95% CI, 1.18-1.39).
From the PMSS results (2011–2015), the national pregnancy-related mortality ratio (PRMR) was
17.2 per 100,000 live births. Black women and American Indian/Alaska Native women had the
highest PRMRs (42.8 and 32.5, respectively), 3.3 and 2.5 times as high, respectively, as the
PRMR for non-Hispanic White women (13.0). Timing of death was known for 87.7% (2,990) of
pregnancy-related deaths. Among these deaths, 31.3% occurred during pregnancy, 16.9% on
the day of delivery, 18.6% 1–6 days postpartum, 21.4% 7–42 days postpartum, and 11.7% 43–
365 days postpartum. Leading causes of death included cardiovascular conditions, infection,
and hemorrhage, and these causes of maternal deaths varied by timing; in pregnancy, during
childbirth and postpartum. About 60% of pregnancy-related deaths from state MMRCs were
determined to be preventable. The MMRC results indicated that multiple factors contributed to
pregnancy-related deaths, and prevention strategies should include improving access to, and
coordination and delivery of, quality care to birthing parents.
Conclusion: Pregnancy-related deaths occurred during pregnancy, around the time of delivery,
and up to 1 year postpartum; leading causes varied by timing of death. 15.7% and 14.1% of
SMM cases in the Medicaid and commercial insurance cohorts, respectively, first occurred after
the delivery hospitalization, with disparities in factors and maternal characteristics associated
with SMM. Approximately 60% of pregnancy-related deaths were preventable.
Keywords: Birthing parents, Medicaid, Medicaid expansion, Medicaid extension, maternal
mortality, maternal safety bundles, severe maternal morbidity.
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1 BACKGROUND AND INTRODUCTION
Maternal morbidity and mortality, considered as problems of the developing world,
remain a major burden in the United States (U.S.) (WHO, 2015). The U.S. has the highest
maternal morbidity and mortality rates among industrialized nations, even when data is limited
to only white women who generally have the lowest rates, suggesting that the maternal health
care system needs a major overhaul (Commonwealth Fund, Issue Brief & Report, December 16,
2020). This is despite the fact the U.S. spends more on health care and medical research for
technological advancement than any other industrialized country. The U.S. ranks 60th in the
world in maternal survival after childbirth (Kozhimannil, Hardeman & Henning-Smith, 2017).
One of the primary drivers of the high maternal mortality in the U.S. is the high rate of severe
maternal morbidity (SMM). Evidence shows that for every maternal death, 50 to 100 women
experience SMM which are life-threatening complications that without timely identification and
proper management, may be associated with deaths (Kilpatrick, Ecker & ACOG., 2016). Also,
over the past few decades, there has been an increase in the rates of many factors associated
with SMM (Creanga et al., 2014). Each year in the U.S., about 1,200 women suffer
complications during pregnancy or childbirth that prove fatal (WHO, 2015) and 60,000 suffer
complications that are near-fatal or result in SMM (Creanga et al., 2014). According to the latest
report of the Centers for Disease Control and Prevention (CDC) on SMM in 2014, it affects over
50,000 women in the United States, and the trend has steadily increased in recent years. Data
from the Pregnancy Risk Assessment Monitoring System (PRAMS) shows that blood
transfusions, hysterectomy, sickle cell disease with crisis, eclampsia, sepsis, and disseminated
intravascular coagulation (DIC) are some of the leading causes of SMM (CDC, 2021) (Table 1).
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SMM, a subset of maternal morbidity, is recognized by the CDC through a list of 21 indicators
and corresponding International Classification of Diseases (ICD) codes. A recent CDC report
showed the following conditions as some of the clinical causes of pregnancy-related mortality
in the US: combination of heart conditions (15%), infections (13%), cardiomyopathy or heart
muscle disease (11%), severe postpartum bleeding (11%), blood clots (9%), high blood pressure
(8%), and stroke (7%) (Commonwealth Fund, 2020). Evidence shows that about 50% of all
maternal deaths in the U.S. are preventable (Main & Menard, 2013).
Medicaid covers about 50% of all pregnancies in the United States, with Black and
Hispanic women having a higher likelihood of being covered by Medicaid in pregnancy than
White women (Markus et al., 2013). In 2020, Medicaid coverage was 29.3% for non-Hispanic
White women, 58.6% for Hispanic women, and 64.7% for non-Hispanic Black women (CDC
NVSS, 2022). Conversely, the percentage of mothers using private insurance in 2020 was 30.1%
for non-Hispanic Black women, 31.3% for Hispanic women, and 63.9% for non-Hispanic White
women (CDC NVSS, 2022). Evidence from other areas of clinical practice shows that uninsured
and patients covered by Medicaid receive a lower quality of care than those on private
insurance or commercial insurance; causes of lower quality care for these patients include
limited use of resources for them due to payor type, and use of lower-quality physicians in the
same hospital for uninsured and Medicaid patients (Boxer et al., 2003; Gardner & Vishwasrao,
2010; Spencer et al., 2013). This poorer quality of care could be one of the drivers of
racial/ethnic differences in the rates of SMM and outcomes. Another driver of the higher rates
of SMM among Black and Hispanic women compared to White women could be the lack of
preconception health insurance coverage to diagnose or treat preexisting medical conditions
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like hypertension or depression, which are risk factors for SMM and mortality (Gray et al.,
2012). Evidence shows that states with preconception health insurance through Medicaid
expansion have lower maternal mortality rates, for which SMM is a significant risk factor
(Searing & Ross., 2019).
About four million births occur yearly in the U.S., making childbirth the leading cause of
hospital admissions for commercial health insurance payers and Medicaid claims (Howell &
Zeitlin, 2017). The estimated annual hospital costs of childbirth and newborns in the US are
over $110 billion (AHRQ-HCUP, 2018). Medicaid covers about half of all deliveries in the
country, with pregnant African American women (66%) and Hispanic women (60%) more likely
to be covered by Medicaid health insurance than are pregnant White women (Markus et al.,
2013; MACPAC, 2020). States are required to provide Medicaid coverage for pregnant women
up to 138% of the federal poverty level (FPL) until 60 days postpartum. Still, gaps in coverage
remain, especially in states that have not expanded Medicaid under the Patient Protection and
Affordable Care Act (ACA) (Eckert, 2020). In non-expansion states, a pregnant woman could
lose her eligibility for regular Medicaid coverage from day 61 of her delivery if her income is
above the state’s FPL level. Particularly prone to lack of health insurance outside of pregnancy
in non-expansion states like Georgia are people of color, low-income individuals and families,
and childless adults with income greater than 40% FPL and less than 100% FPL except those
with disabilities (Eckert, 2020). Also, about 50,000 women or more die from post-birth severe
complications which may require long-term care beyond the 60-days post-birth coverage of
regular Medicaid or 180-days coverage in Georgia through H.B. 1114 (Davis et al., 2019;
Petersen et al., 2019). Evidence shows the harmful effects of “churning," i.e., disruptions in
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healthcare insurance coverage, especially Medicaid, which occurs most often during the critical
postpartum period, on maternal and infant health outcomes including preterm births, and
SMMs (Eckert, 2020). Perinatal insurance churn is observed in both Medicaid expansion (33%)
and non-expansion states (50%), but more prevalent among individuals who depend on
Medicaid for pregnancy-related care (Daw et al., 2019).
Studies have shown that lack of preconception health insurance including in individuals
with preexisting chronic conditions, is associated with later prenatal care, suboptimal use of
pregnancy care, and more significant risks of poor birth and birth-related outcomes that can
endanger the lives of birthing parents (Adams et al., 2019). Black, Latina, and Indigenous
women are disproportionately affected by a lack of preconception health insurance coverage.
Evidence shows that from 2015 to 2017, about 50% of all non-Hispanic Black women had noncontinuous coverage from preconception to post-birth, and 50% of Latina women became
uninsured in the postpartum period (Daw et al., 2020). Also, using data from the Nationwide
Inpatient Sample (NIS), Howell et al. (2016) found that Black women deliver in a concentrated
set of hospitals with higher risk adjusted SMM rates for both White and Black deliveries. About
700 birthing parents die from pregnancy-related complications every year in the U.S. with
significant racial/ethnic disparities; Black women have a pregnancy-related mortality ratio
approximately three times as high as that of White women (Creanga et al., 2017; Petersen et
al., 2019).
According to the WHO (2015), three factors are the leading causes of the upward trend
in maternal morbidity and mortality in the U.S. First, there is an increasing number of birthing
people who attend prenatal care clinics with untreated or poorly managed chronic conditions
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due to lack of health insurance. These conditions like diabetes, hypertension and mental health
issues are drivers of pregnancy-related complications. These individuals could benefit from
community-based services including case management to help them access needed healthcare
and overcome cost and other obstacles to care. Evidence shows that birthing people who lack
health insurance are three to four times more likely to die of pregnancy-related complications
than those who are insured (Berg et al., 2003). In 2018, 30% of pregnancy-related deaths in the
U.S. occurred between 43 days and one year postpartum, and some of these deaths occur
outside of the 60-day coverage of pregnancy-related Medicaid (NCHS, 2018). Keeping birthing
people insured postpartum helps them maintain access to their providers, helps their providers
to detect signs of complications early, screen them for postpartum depression, and manage any
chronic conditions which will improve maternal and child outcomes. A second factor for the
increased maternal morbidity and mortality in the U.S. according to the WHO is the
inconsistency in the quality of obstetric practice in the country. The healthcare system,
including hospitals and birthing centers, lack a uniform and standardized approach to managing
obstetric emergencies, causing late recognition of pregnancy, childbirth, and postpartum
complications (D'Alton et al., 2014). The third factor is the paucity of good data and related
analysis. Maternal mortality data are missing for about half of all the states and territories in
the U.S. and the expectation is that subsequent annual reports will combine multiple years to
enable comparison of data for all states (Declercq & Zephyrin, 2020).
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1.1

Purpose of the Study
The aim of this policy review and analysis is to evaluate the association between health

insurance status, type, and duration of coverage on the incidence and outcomes of SMM and
mortality in the U.S.
1.1.1 Research Questions
1. Is preconception health insurance status related to the rates of SMM and mortality?
2. Does the standardized use of rapid-cycle Maternal Data Center and Maternal Safety
Bundles lead to improved quality of care for birthing parents?
3. Is extended postpartum Medicaid/CHIP insurance coverage to a year after childbirth
correlated with a decrease in the mortality rate and improved SMM outcomes?
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2

METHODS

This policy review and analysis used PubMed, Google Scholar, Science Direct, Cochrane
Library and EMBASE to search for studies on health insurance status, payor type, demographic
characteristics, preconception, prenatal and postnatal coverage, SMM and maternal mortality.
A review of the results of multi-state and national studies was done to evaluate the relationship
between health insurance status, payor type, and duration of coverage on the incidence,
timing, and outcome of SMM.
A retrospective cohort study by Chen et al. (2021) from 2010-2014 used data from the IBM
MarketScan Multi-State Medicaid database and the IBM MarketScan Commercial Claims and
Encounters database to evaluate timing of SMM during delivery hospitalization of 2,667,325
women aged 15-44 years. Women with at least one factor for SMM were identified using
diagnosis and procedure codes from the International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) for the 21 factors associated with SMM. Each birthing parent in
the sample was classified into 3 outcome groups: (1) those who had no SMM during the
delivery hospitalization and the postdelivery (discharge) period, (2) those who had at least one
factor of SMM during the delivery hospitalization, and (3) those who had any factor associated
with de novo SMM after delivery discharge. De novo SMM after delivery discharge is defined as
SMM first diagnosed during the 6 weeks (42 days) after discharge from delivery hospitalization
unrelated to any factor with SMM identified during delivery. To ensure that true de novo SMM
cases were identified, birthing parents who had any SMM event in the two months preceding
delivery hospitalization (1,043 in the Medicaid cohort and 1,186 in the commercial insurance
cohort) were excluded.
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Results from the national Pregnancy Mortality Surveillance System (PMSS) of the Centers
for Disease Control and Prevention (CDC) for 2011-2015 was reviewed to evaluate pregnancyrelated deaths by sociodemographic characteristics, timing relative to end of pregnancy, and
the leading causes of death. The Division of Reproductive Health, CDC, requests that all states,
the District of Columbia, and New York City send death certificates, linked live birth or fetal
death certificates, and additional data when available, on deaths that occurred during
pregnancy or within 1 year after delivery. Coding of the cause of death includes these 10
mutually exclusive SMM categories: anesthesia complications; amniotic fluid embolism;
cardiomyopathy; cerebrovascular accidents; hemorrhage; hypertensive disorders of pregnancy
(preeclampsia or eclampsia); infection; thrombotic pulmonary or other embolism (air, fat, or
septic); other cardiovascular conditions (cardiac valvular disease, congenital heart disease,
congestive heart failure, and ischemic heart disease); and other non-cardiovascular medical
conditions (endocrine, hematologic, immunologic, and renal).
Results from 13 state maternal mortality review committees (MMRCs) from 2013-2017 on
pregnancy-related deaths was reviewed to identify predisposing factors and preventability.
Each multidisciplinary MMRC used a standardized data collection system to review available
data sources (autopsy reports, medical records, social service records, and vital records) in
determining preventability, and contributing factors to the deaths. The study excluded deaths
from drug overdose, homicide, suicide, and unintentional injury from analyses.
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3

RESULTS

The retrospective cohort study of delivery hospitalizations of 2,667,325 birthing people in
the U.S. from 2010-2014 showed that 809,377 (30.3%) of them had Medicaid coverage and
1,857,948 (69.7%) had commercial insurance coverage. In the Medicaid cohort, 51.1% were
White, 33.2% Black, 5.1% Hispanic, and 10.6% were of another race or ethnicity. In the
commercial insurance cohort, 17.1% were from the northeastern region, 20.0% from the north
central region, 36.4% from the southern region, and 20.6% from the western region of the U.S.
(Table 1 and Table 2). In total, 17,584 (2.2%) birthing parents in the Medicaid cohort and 32,079
(1.7%) birthing parents in the commercial insurance cohort had at least one SMM factor
identified during the delivery hospitalization. In total, 3,265 (0.4%) birthing parents in the
Medicaid cohort and 5,275 birthing parents (0.3%) in the commercial insurance cohort had de
novo SMM after delivery discharge; de novo SMM cases after discharge was 15.7% of total
SMM cases in the Medicaid cohort and 14.1% of total SMM cases in the commercial insurance
cohort (Table 1). In this cohort study of 2 667 325 women in the US with delivery
hospitalizations between 2010 and 2014, 14% and 16% of SMM among those with commercial
and Medicaid insurance, respectively, developed de novo within 6 weeks after delivery
discharge. The most common factors and maternal characteristics associated with SMM after
delivery were different than those identified at delivery.

A similar pattern was found for birthing parents with Medicaid and commercial insurance in
analysis of the timing of the first episode of SMM; the number of SMM cases post delivery was
highest within the first week of delivery hospitalization, decreasing rapidly after the second
week. A total of 2,399 birthing parents (73.5%) in the Medicaid cohort and 3,993 birthing
9
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parents (75.7%) in the commercial insurance cohort with de novo SMM after discharge were
diagnosed in the first 2 weeks after discharge from the delivery hospitalization. However, in the
Medicaid cohort, only Black women had a higher likelihood (adjusted odds ratio [OR] 1.69; 95%
CI, 1.57-1.81) of experiencing SMM in the postdelivery discharge period compared with White
women. While in the commercial insurance cohort during the delivery hospitalization, residing
in the western region compared with the northeastern region was associated with a higher
likelihood of SMM (aOR, 1.37; 95% CI, 1.32-1.41). In the post-delivery discharge period, residing
in the southern region of the U.S. compared with the northeastern region was associated with a
higher likelihood of SMM (aOR, 1.29; 95% CI, 1.18-1.39).

Table 1: Severe maternal morbidity diagnosis by timing of diagnosis and insurance type (2010-2014a).
Timing of
diagnosis

Medicaid
N (%)

Commercial
95% CI, %

Total

95% CI, %

N (%)

N (%)

95% CI, %

NA

1,857,948

NA

2,667,325

NA

97.4-97.5

1,820,594 (98.0)

98.0-98.0

2,609,122 (97.8)

97.8-97.8

2.1-2.2

32,079 (1.7)

1.7-1.8

49,663 (1.9)

1.8-1.9

0.4-0.4

5,275 (0.3)

0.3-0.3

8,540 (0.3)

0.3-0.3

NA

37,354

NA

83.8-84.8

32,079 (85.9)

85.5-86.2

NA

NA

15.1-16.2

5,275 (14.1)

13.8-14.5

All women
Total
809,377
participants, N
No SMM during 788,528 (97.4)
and after
delivery
hospitalization
Any SMM
17,584 (2.2)
during delivery
hospitalization
Any de novo
3,265 (0.4)
SMM during
postpartum
hospitalization
Women with SMM
Total
20,849
participants, N
Any SMM
17,584 (84.3)
during delivery
hospitalization
Any de novo
3,265 (15.7)
SMM during
postpartum
hospitalization
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Abbreviations: NA, not applicable; SMM, severe maternal morbidity.
Source: aData were obtained from the 2010-2014 IBM MarketScan Multi-State Medicaid and IBM MarketScan
Commercial Claims and Encounters databases. Pearson χ2 test for the equal distribution of different SMM status
across 2 populations: χ2 = 871.99; P < .001.

Table 2: Maternal characteristics by insurance type and timing of diagnosis (2010-2014).
Characteristics by
insurance type
Medicaid
Total participants, N
Age group, yrs.
15-24
25-34
35-44
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Othera
Fetal outcome
No stillbirth
Any stillbirth
Delivery method
Vaginal
Cesarean
Commercial
Total participants, N
Age group, yrs.
15-24
25-34
35-44
Census region
Northeast
North central
South
West
Unknown
MSA status
MSA
Non-MSA
Unknown
Fetal outcome
No stillbirth
Any stillbirth
Delivery method
Vaginal
Cesarean

No SMM during and
after delivery
hospitalization, N (%)

Any SMM during
delivery
hospitalization, N (%)

Any de novo SMM
during postpartum
hospitalization, N (%)

Total, N (%)

788,528

17,584

3,265

809,377

386,384 (49.0)
341,399 (43.3)
60,745 (7.7)

8,210 (46.7)
7,447 (42.4)
1,927 (11.0)

1,271 (38.9)
1,580 (48.4)
414 (12.7)

395,865 (48.9)
350,426 (43.3)
63,086 (7.8)

404,793 (51.3)
259,532 (32.9)
40,471 (5.1)
83,732 (10.6)

7,185 (40.9)
7,373 (41.9)
973 (5.5)
2,053 (11.7)

1,367 (41.9)
1,507 (46.2)
115 (3.5)
276 (8.5)

413,345 (51.1)
268,412 (33.2)
41,559 (5.1)
86,061 (10.6)

780,804 (99.0)
7,724 (1.0)

16,936 (96.3)
648 (3.7)

3,211 (98.3)
54 (1.7)

800,951 (99.0)
8,426 (1.0)

544,187 (69.0)
244,341 (31.0)

6,489 (36.9)
11,095 (63.1)

1,638 (50.2)
1,627 (49.8)

552,314 (68.2)
257,063 (31.8)

1,820,594

32,079

5,275

1,857,948

254,357 (14.0)
1,131,666 (62.2)
434,571 (23.9)

4,221 (13.2)
18,409 (57.4)
9,449 (29.5)

722 (13.7)
2,918 (55.3)
1,635 (31.0)

259,300 (14.0)
1,152,993 (62.1)
445,655 (24.0)

311,153 (17.1)
436,947 (24.0)
663,079 (36.4)
372,119 (20.4)
37,296 (2.1)

5,639 (17.6)
6,635 (20.7)
10,240 (31.9)
8,796 (27.4)
769 (2.4)

800 (15.2)
1,185 (22.5)
2,207 (41.8)
975 (18.5)
108 (2.0)

317,592 (17.1)
444,767 (23.9)
675,526 (36.4)
381,890 (20.6)
38,173 (2.0)

1,553,440 (85.3)
230,320 (12.7)
36,834 (2.0)

27,477 (85.7)
3,928 (12.2)
674 (2.1)

4,470 (84.7)
699 (13.3)
106 (2.0)

1,585,387 (85.3)
234,947 (12.6)
37,614 (2.0)

1,806,700 (99.2)
13,894 (0.8)

31,324 (97.6)
755 (2.4)

5,202 (98.6)
73 (1.4)

1,843,226 (99.2)
14,722 (0.8)

1,178,674 (64.7)
641,920 (35.3)

12,640 (39.4)
19,439 (60.6)

2,411 (45.7)
2,864 (54.3)

1,193,725 (64.2)
664,223 (35.8)
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Abbreviations: MSA, metropolitan statistical area (as defined by the US Office of Management and Budget); SMM,
severe maternal morbidity.
a
Specific races included in this category were not available in the database.
Source: Data were obtained from the 2010-2014 IBM MarketScan Multi-State Medicaid and IBM MarketScan
Commercial Claims and Encounters databases.

From the PMSS data (2011–2015), the national pregnancy-related mortality ratio (PRMR)
was 17.2 per 100,000 live births. Black women and American Indian/Alaska Native women had
the highest PRMRs (42.8 and 32.5, respectively), 3.3 and 2.5 times as high, respectively, as the
PRMR for non-Hispanic White women (13.0). The PRMR was highest among birthing parents
aged ≥35 years and unmarried birthing parents. The overall PRMR had yearly fluctuations,
ranging from low of 15.9 in 2012 to a high of 18.0 in 2014 (Table 3). Leading causes of death
included cardiovascular conditions, infection, and hemorrhage, and varied by timing. In
combination, cardiovascular conditions account for >33% of pregnancy-related deaths;
cardiomyopathy (10.8%), other cardiovascular conditions (15.1%), and cerebrovascular
accidents (7.6%); non-cardiovascular medical conditions (14.3%); infection (12.5%); obstetric
hemorrhage (11.2%); and undetermined (6.7%). Timing of death was known for 87.7% (2,990)
of pregnancy-related deaths. Among these deaths, 31.3% occurred during pregnancy, 16.9% on
the day of delivery, 18.6% on 1–6 days postpartum, 21.4% on 7–42 days postpartum, and 11.7%
43–365 days postpartum (Table 4). There was no significant difference in the timing of deaths
between Black and White birthing parents for most periods. However, a greater proportion of
pregnancy-related deaths among Black people (14.9%) occurred 43–365 days postpartum
compared to the proportion among White maternal deaths (10.2%) during the same period
(p<0.01).
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Table 3: Pregnancy-related deaths, by sociodemographic characteristics.
Characteristic
No. of pregnancy-related deaths
Pregnancy-related mortality ratio*
(N=3,410)
(Average=17.2)
Race/Ethnicity (N = 3,400)
White
1,385
13.0
Black
1,252
42.8
American Indian/Alaska Native
62
32.5
Asian/Pacific Islander
182
14.2
Hispanic
519
11.4
Age group (yrs.) (N = 3,409)
<20
158
11.3
20–24
543
12.1
25–29
751
13.2
30–34
799
15.3
35–39
706
28.7
≥40
452
76.5
Highest level of education (N =
2,938)
Less than high school
572
19.8
High school graduate
1,090
24.2
Some college
775
14.8
College graduate or higher
501
9.4
Marital status (N = 3,371)
Married
1,543
13.1
Not married
1,828
22.8
Year
2011
702
17.8
2012
627
15.9
2013
679
17.3
2014
718
18.0
2015
684
17.2
Source: Pregnancy Mortality Surveillance System, United States, 2011–2015
* Number of pregnancy-related deaths per 100,000 live births.

Also, the leading causes of pregnancy-related death varied by time relative to the end of
pregnancy (Figure 1). During pregnancy, cardiovascular conditions and other non-cardiovascular
conditions were the leading causes of pregnancy-related death; on delivery day, hemorrhage
and amniotic fluid embolism were the leading causes of maternal deaths; during the first 6 days
postpartum, infection, hemorrhage and hypertensive disorders of pregnancy were the main
causes of maternal death; and from 6 weeks after childbirth (43 days) up to a year (365 days)
postpartum, cardiomyopathy was the leading cause of pregnancy-related death.
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About 60% of pregnancy-related deaths from state MMRCs were determined to be
preventable. MMRC data indicated that multiple factors contributed to pregnancy-related
deaths. According to the MMRCs, contributing factors to pregnancy-related deaths and
prevention strategies can be categorized at the community, health facility, patient, provider,
and system levels and include improving access to, and coordination and delivery of, quality
care. (Petersen et al., 2019).

Table 4: Pregnancy-related deaths, by cause of death and time of death relative to the end of pregnancy
Cause of death†
Hemorrhage
Infection
Amniotic fluid
embolism
Thrombotic pulmonary
or other embolism
Hypertensive disorders
of pregnancy
Anesthesia
complications
Cerebrovascular
accidents
Cardiomyopathy
Other cardiovascular
conditions
Other
noncardiovascular
medical conditions
Unknown
Total

N (%) attributed to each cause
1–6 days
7–42 days
postpartum
postpartum
105 (31.9)
27 (8.2)
83 (23.1)
121 (33.6)
42 (24.3)
4 (2.3)

During
pregnancy
72 (21.9)
117 (32.5)
12 (6.9)

Day of
delivery
123 (37.4)
17 (4.7)
114 (65.9)

43–365 days
postpartum
2 (0.6)
22 (6.1)
1 (0.6)

Total no. of
deaths
329
360
173

115 (40.9)

24 (8.5)

41 (14.6)

69 (24.6)

32 (11.4)

281

23 (10.8)

41 (19.3)

94 (44.3)

44 (20.8)

10 (4.7)

212

2 (20.0)

3 (30.0)

3 (30.0)

2 (20.0)

0

10

68 (29.8)

9 (3.9)

49 (21.5)

79 (34.6)

23 (10.1)

228

48 (15.6)
173 (37.6)

21 (6.8)
65 (14.1)

25 (8.1)
61 (13.3)

75 (24.4)
110 (23.9)

138 (45.0)
51 (11.1)

307
460

225 (52.7)

61 (14.3)

27 (6.3)

59 (13.8)

55 (12.9)

427

82 (40.4)
937 (31.3)

28 (13.8)
506 (16.9)

26 (12.8)
556 (18.6)

50 (24.6)
640 (21.4)

17 (8.4)
351 (11.7)

203
2,990

Source: Pregnancy Mortality Surveillance System, United States, 2011–2015*
† Cause of death categories are mutually exclusive.
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Figure 1: Leading causes of pregnancy-related death, by timing of death.

Source: Adapted from Petersen EE, Davis NL, Goodman D, et al., 2019. Vital signs: pregnancy-related deaths,
United States, 2011-2015, and strategies for prevention, 13 states, 2013-2017. MMWR Morb Mortal Wkly Rep.
2019; 68:423-429. Note: Cardiac conditions include both cardiomyopathy and other cardiovascular disease.

3.1

Policy Analysis and Review
3.1.1 Pregnancy Medicaid and Postpartum Coverage Extension Policies
Congress established the 60-day post birth Medicaid coverage cut-off through the

Omnibus Budget Reconciliation Act of 1986 (P.L. 99-509) (MACPAC, April 2021), at a time when
the medical community had a comparably limited understanding of the postpartum period,
making the policy of a 60-day postpartum coverage for birthing people antiquated (Health
Affairs, 2021). Medicaid programs cover eligible pregnant people with incomes below 138% FPL
through 60 days after giving birth. Eligibility levels for pregnant women across states for
Medicaid and Children Health Insurance Program (CHIP) range from a low of 138% FPL in Idaho
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and South Dakota to a high of 380% FPL in Iowa. A total of 35 states cover pregnant parents at
or above 200% FPL (Brooks et al., 2021). For close to 40 years, federal law guaranteed
automatic health insurance coverage for babies born to Medicaid-enrolled parents, from birth
through the first year of life. Hence, while many birthing parents lose their Medicaid coverage
from 61 days postpartum, their infants have continued coverage for a year (Commonwealth
Fund, 2021). Adopting a year of continuous Medicaid eligibility through the State Plan
Amendment (SPA) postpartum one year extension for birthing parents and their infants who
maintain coverage for one year post birth, would close the coverage gaps while also reducing
the paperwork for state insurance agencies. The postpartum period is critical to the health and
well-being of birthing parents and their newborn as it sets the stage for long-term health and
well-being for the mother-infant dyad. During the postpartum period, the birthing parent is
adapting to various physical, social, and psychological changes as well as recovering from
childbirth, adjusting to changing hormones in her body and learning to feed and care for her
newborn (ACOG, 2018). Hence, the American College of Obstetricians and Gynecologists
(ACOG) recommends ongoing comprehensive care for birthing parents, including physical,
social, and psychological services in the postpartum period (ACOG, 2018; HCCI, 2020).
Six states (Colorado, Missouri, New Jersey, Rhode Island, Virginia, and West Virginia)
have expanded coverage for pregnant women through CHIP, either through an option for states
that cover pregnant women in Medicaid up to at least 185% FPL or a continuation of an existing
Section 1115 waiver (Brooks et al., 2021; MACPAC, 2022). Also, 36 states and the District of
Colombia currently extend eligibility beyond 60 days postpartum, and these states by extending
insurance coverage to low-income pregnant women, lowered the financial hurdles that limit
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access to antenatal care for millions of birthing people (HCCI, 2020). Reapplying for coverage
after the expiration of pregnancy Medicaid from day-61 postpartum often entails long hours of
commute and in-person visit to a local benefits office, a considerable barrier for new parents
managing their newborn’s unpredictable schedule and their own physical and emotional
recovery after delivery (Georgetown University Health Policy Institute, 2021a).
Over 275 advocacy groups, national and state healthcare provider organizations, along
with state MMRCs and departments of health, recommend that states extend postpartum
Medicaid coverage to one year. The Medicaid and CHIP Payment and Access Commission
(MACPAC) gave a strong endorsement of this policy by recommending to Congress in 2021, 12
months of postpartum coverage for pregnant individuals in Medicaid at 100% federal medical
assistance percentage (FMAP) or matching rate, and to align the policy in states that expand
CHIP coverage to pregnant women (Georgetown University Health Policy Institute, 2021a).
The Congressional Budget Office (CBO) combined average cost estimate to provide 10
additional months of Medicaid coverage for states and federal government is about $1,500 per
individual in 2022. This amount is expected to increase by about 6% over the 2022-2030 period.
The CBO estimates that coverage extension to a year postpartum would increase Medicaid’s
direct spending by $6.1 billion over the 2021-2030 period and the costs would be about the
same for an additional 10 months of coverage under CHIP. Estimate shows that by 2024,
because only 6 states extend CHIP coverage to birthing people, fewer than 1,000 pregnant
parents would reside in a state implementing the option thereby increasing direct spending by
$5 million over the 2021-2030 period (CBO, 2021).
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3.1.2 Patient Protection and Affordable Care Act (2010)
Before the Patient Protection and Affordable Care Act (ACA), some birthing parents with
individual health plans wrongly assumed that they had maternity coverage only to find out
when they are pregnant that they are not covered by their plan. Some of these individuals
believed that if they maintained continuous coverage, they would be able to purchase a plan
with maternity care when they need it, but they were wrong and disappointed when they
found out it was not the case (Norris, 2020). In all states, every new small group health
insurance plan must include maternity benefits, and though small employers with less than 50
employees are not required to offer health insurance coverage under the ACA, if they do, the
plan must include maternity benefits (Norris, 2020). It should be noted that before the ACA,
maternity coverage was available on most employer-sponsored group plans due to the 1978
Pregnancy Discrimination Act (PDA). The PDA mandates that if an employer with 15 or more
employees opts to provide health insurance coverage, it must include maternity benefits.
In 2010 the ACA included antenatal and maternal care as one of the 10 essential health
benefits that insurance plans on the Health Insurance Marketplace (also called Marketplace) or
Medicaid must cover for pregnant women (March of Dimes, 2020). The Marketplace is an
online resource that helps prospective enrollees to find and compare health plans in their state.
Under the ACA, maternity care coverage is included in all individual and small group plans
effective January 1, 2014, or later. Medicaid through the ACA covers about 50% of births
nationwide with eligibility levels ranging from 138% FPL to 380% FPL across states. States are
mandated by the ACA to cover pregnant people with incomes up to 138% FPL through 60 days
post birth, i.e., end of the month of the 60th postpartum day (Ranji, Salganicoff & Gomez,
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2021). In non-expansion states, Medicaid income eligibility levels for parents and other adults
are much lower; median eligibility levels for parents in the 12 non-expansion states is 40% FPL
($8,784 per year for a family of three), ranging from as low as 17% FPL in Texas to as high as
100% FPL in Wisconsin. The non-expansion states are Alabama, Florida, Georgia, Kansas,
Mississippi, North Carolina, South Carolina, South Dakota, Tennessee, Texas, Wisconsin, and
Wyoming (KFF, 2022). In these non-expansion states, some new parents fall into the ‘coverage
gap’ as their incomes are much higher than parent eligibility levels but too low to qualify for
Marketplace subsidies (available only at 100% FPL or above). Parents that fall into this gap are
at risk of becoming uninsured from 61 days postpartum. In expansion states, most postpartum
parents have a pathway to coverage after 60 days postpartum: either Medicaid or subsidized
private insurance in the ACA Marketplaces. However, studies show that new parents with
Medicaid funded childbirths experience significant churning in coverage (Daw, Kozhimannil &
Admon, 2019).
3.1.3 American Rescue Plan Act (2021)
The American Rescue Plan Act (ARP) of 2021 enables states to lengthen eligibility for
pregnancy-related Medicaid coverage from the current 60 days postpartum to up to one year, a
time when mothers remain at elevated pregnancy-related health risk (Ranji, Salganicoff &
Gomez, 2021). Prior to the ARP, states intending to extend postpartum coverage beyond 60
days had to use Medicaid Section 1115 demonstration waivers. Currently, Centers for Medicare
and Medicaid Services (CMS) has approved this unique extended postpartum coverage waivers
in Georgia (6 months of extended coverage for all pregnant people in Medicaid), Illinois (12
months of postpartum coverage for all pregnant people in Medicaid), and Missouri (12 months
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of limited postpartum benefits for only postpartum individuals with a substance use disorder
diagnosis). Some states either have waivers pending or have plans to submit waivers.
(Georgetown University Health Policy Institute, 2021a). As an alternative to demonstration
waivers, the ARP gives states the option to use the Medicaid State Plan Amendment (SPA)
beginning April 1, 2022. For states seeking to extend postpartum coverage, SPA has advantages
in terms of the federal approval process and funding. For birthing people, SPA has advantages
in terms of eligibility, benefits covered, and provider choice. Compared to waivers that can
offer comprehensive postpartum coverage or in some states have limits on populations or
benefits covered, the ARP option extends postpartum coverage for one year with full Medicaid
benefits. It is estimated that about 123,000 uninsured birthing people would benefit from the
SPA one-year postpartum extension, covering more birthing persons over a longer period
(Commonwealth Fund, 2021). Colorado, Missouri, New Jersey, Rhode Island, Virginia, and West
Virginia are the 6 states that currently provide coverage to pregnant people under CHIP. For
states that choose an SPA option, the one-year postpartum Medicaid coverage extension will
also apply to CHIP-enrolled pregnant people, however, this might not be the case for the waiver
option (Commonwealth Fund, 2021).
Through the ARP, states receive their regular Medicaid matching rate (FMAP) for the
extended coverage period and the option sunsets after five years from April 1, 2022. States’
regular Medicaid FMAP currently ranges from 56.2% - 84.51%, enhanced due to the public
health emergency. This ARP provision for participating states means that birthing people who
are citizens or legal residents could maintain their Medicaid coverage postpartum beyond the
traditional 60-day period up to one year with limited out-of-pocket spending and no need to
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sign up for a new plan (Ranji, Salganicoff & Gomez, 2021). Surprisingly, in non-expansion states
like Florida, Georgia, and Texas, their lawmakers chose the extended postpartum coverage
(Section 1115 waiver) instead of Medicaid expansion, a less effective and more costly option.
Waiver extension is more costly than Medicaid expansion for states because the 10 additional
months of postpartum coverage beyond the 60 days are matched at the state’s regular FMAP
rate (56.2% - 84.51%) compared to the 90% enhanced FMAP of Medicaid expansion under the
ACA and the additional 5% in the first 2 years for new Medicaid expansion states under the ARP
(Georgetown University Health Policy Institute, 2021b)
ARP falls short, however, because undocumented birthing people would still be
ineligible for Medicaid coverage because federal funds cannot be used to support
undocumented immigrants for Medicaid. Nevertheless, states taking advantage of Medicaid
expansion provision in the ARP could concurrently use state funds to provide Medicaid
coverage for undocumented birthing people in the postpartum period up to one year postdelivery (Health Affairs, 2021).
3.1.4 Financial Costs of Continuous Postpartum and Preconception Medicaid
Coverage
According to the Congressional Budget Office (CBO), the estimated average cost to
provide 10 additional months of postpartum Medicaid coverage is $1,500 per person in 2022.
Expectedly, more than half of this cost would be covered by federal dollars (depending on a
state’s federal matching level). However, states would cover the full cost of Medicaid coverage
to undocumented birthing people. For instance, it would cost New York less than a tenth of 1
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percent of total state Medicaid spending to provide one year of postpartum coverage to
undocumented birthing people (Health Affairs, 2021).
According to the Health Care Cost Institute (2020), birthing parents’ spending spans the
full year following childbirth. Although about 20% of overall postpartum spending was in the
first 60 days, and about 30% was in the first 90 days, approximately 70% of birthing parents
spending occurred over the rest of the year (Figure 2). Spending per person was $580 and $870
for the first for the 60 days and 90 days postpartum, respectively. However, over the course of
the full postpartum year, per person spending was above $3,100. Also, the study showed age
differences in postpartum spending per person; birthing parents aged 25-34 years
(approximately 60% of study sample) had the lowest per person spending of $2, 904, while
birthing parents aged 45-54 years (less than 0.5% of study sample) had a 50% higher average
spending of $4,634 (HCCI, 2020) (Table 5).
Table 5: Full-Year Postpartum Spending by Age Group (2016)
Age Band (Years)

Average spending per person (2016)

18-24
25-34
35-44
45-54
Source: Health Care Cost Institute (2020).

$3,667
$2,904
$3,373
$4,634

Proportion of sample
(2016)
9.9%
61.4%
28.2%
0.4%

Figure 2: Spending across the postpartum year

Source: Heath Care Cost Institute (2020)
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3.2

Policy Recommendations and Interventions
A key component of quality is having access to the appropriate care at the right time.

Although access and quality are two important ways clinicians can reduce or prevent SMM and
maternal mortality, other factors affect the need for, access to, quality and outcomes of
maternity care (Kozhimannil, Hardeman & Henning-Smith, 2017).
3.2.1 Medicaid Expansion
Access to health care outside of pregnancy remains a significant challenge for lowincome women, rural women, and women of color, especially in the 12 states that are yet to
expand Medicaid coverage. With over 50% of pregnancies unplanned among women of all
races, preconception care to treat preexisting medical conditions becomes particularly
important, especially among racial/ethnic minority women who carry an excessive SMM and
maternal mortality burden. The median eligibility limit in 2019 for parents in non-expansion
states was 40% FPL or $8,532 per year for a family of three compared to the minimum parental
eligibility limit of 138% FPL or $29,435 per year for a family of three in states with Medicaid
expansion. In non-expansion states, women of childbearing age without a child under 18 years
of age (dependent child) or not pregnant are ineligible for health insurance coverage except
they have a severe disability.
As of January 2021, the median income eligibility limit for Medicaid in the United States
is 200% FPL for the period of pregnancy up to 60 days from the date of delivery, albeit some
non-expansion states like Georgia have partial expansions up to 180 days postpartum. While
this high-income eligibility limit means that a woman's pregnancy and delivery are covered, the
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same woman may be without health insurance coverage before getting pregnant, and in the
critical months following delivery, the so-called coverage churn (Daw et al., 2017). The coverage
churn experienced by low-income women postpartum is one of the drivers of the high maternal
deaths. Some of these women may have pregnancy-related complications due to undiagnosed
or untreated/poorly managed preexisting medical conditions that require long-term treatment
beyond the 60 days postpartum period of regular Medicaid or the 180 days postpartum
Medicaid extension in some states like Georgia. One of the MMRC reports found that 18% of
maternal deaths occurred between 43 days and one year after delivery, and 58.3% of the
deaths were preventable. Increasing access to care through health insurance coverage prepregnancy and up to a year postpartum was recommended to avert maternal deaths (MMRC,
2018).
A systematic review found that Medicaid expansion through the ACA improved access
to health care through increased preconception and postpartum coverage with reductions in
uninsurance, insurance churn, private insurance, and maternal mortality (Bellerose, Collin &
Daw, 2022). Medicaid expansion states that provide coverage for reproductive age women (1549 years) pre-pregnancy and continuing postpartum have had a steady decrease of about 6 to 7
maternal deaths per 100,000 live births. This reduction in maternal deaths was significantly
higher among non-Hispanic Black women (16.27) and Hispanic women (6.01) (Eliason, 2020).
3.2.2 Medicaid Extension
Medicaid extension will also significantly increase access of birthing people to health
coverage, and support parent and infant health. The Medicaid extension option allows states to
submit a Medicaid SPA to receive FMAP for an additional 10 months of full coverage for
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birthing parents after the end of the 60-day postpartum Medicaid and CHIP eligibility. States
would receive their regular matching rate for the additional months of coverage. According to
CBO estimates in 2020, Medicaid and CHIP provided pregnancy-related coverage to about 2
million women with approximately 1.8 million carrying their pregnancy to term. About 35% of
those enrollees have income above 138% FPL. Regardless of whether a state decides to provide
optional coverage to eligible parents, it must reevaluate applicants’ eligibility for other
coverage before the expiration of the 60-day postpartum period (CBO, 2021).
Medicaid Coverage Under the 12-Month Option: Under current law, CBO estimates that after
Medicaid pregnancy coverage ends at 60 days postpartum, about HALF of all birthing parents
covered (45%) become uninsured. About 30% of postpartum parents continue to receive
comprehensive services from Medicaid, and about 30% enroll either in marketplace coverage
or in employment-based plans. A lot of pregnant parents become uninsured due to the wide
gap in Medicaid eligibility levels in pregnancy (200% FPL on average) compared with other
eligibility groups; 138% FPL for Medicaid expansion state parents and an average of 45% FPL for
parents in Medicaid non-expansion states. Section 3102 would provide birthing parents in
states that exercise the option with 10 additional months of Medicaid coverage.
CHIP Coverage for Pregnant and Postpartum Women: Under current law, states can provide
CHIP coverage to eligible pregnant parents and for 60 days postpartum. However, CHIP cannot
be used to replace existing Medicaid coverage for pregnant parents. For pregnant parents to be
covered under CHIP, states must provide, at a minimum, Medicaid coverage to women whose
income is up to 185% FPL. In 2020, about 15,000 birthing parents received pregnancy and
postpartum care under CHIP. According to CBO estimates, all those parents became ineligible
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for comprehensive Medicaid and CHIP services at the end of the 60-day postpartum period.
Also, states can provide CHIP-funded coverage to pregnant parents through a SPA or a
continuation of an existing Section 1115 waiver. Six states (Colorado, Missouri, New Jersey,
Rhode Island, Virginia, and West Virginia) enroll pregnant women in CHIP-funded coverage
(MACPAC, 2022).
Private Health Insurance for Pregnant and Postpartum Women: Some women whose Medicaid
coverage ends after the 60-day postpartum period enroll in private health insurance. According
to CBO estimates in states that implement the option under section 3102, fewer than 5% of
parents who become ineligible each year for Medicaid or CHIP currently have coverage through
a marketplace and 30% enroll in employment-based coverage. It is projected that under section
3102 over the 2021-2030 period, approximately 10,000 and 100,000 birthing parents annually
would delay enrollment for about 10 months either in marketplace coverage or in employmentbased coverage, respectively (CBO, 2021).
3.2.3 Improving the Quality and Safety of Maternal Care
A 2018 report of the CDC based on MMRCs review of 237 maternal deaths in nine states
showed that better quality of care could have prevented 63% of the deaths. Most of these
maternal deaths resulted from provider, facility, and system factors including inadequate
clinical skills, delayed recognition of complications, delayed or ineffective management of
obstetric emergencies, and lack of coordination of care between providers (Report of 9 MMRCs,
2018).
In 2015, the federal Maternal and Child Health Bureau (MCHB) funded by the Health
Resources and Services Administration (HRSA) formed the Alliance for Innovation in Maternal
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Health (AIM). AIM is led by ACOG which collaborates with over 25 national organizations
working in 44 states including D.C. and about 1,766 birthing facilities, on the use of maternal
safety bundles. AIM operates through state health systems to align national, state, and hospital
level efforts to improve maternal safety and health outcomes (ACOG, 2022). The maternal
safety bundles are evidence-based best practices and protocols for use in maternity care and
obstetric complications in hospital and outpatient settings. These safety bundles are for
obstetric hemorrhage, severe hypertension in pregnancy, reduction of cesarean births, heart
conditions in maternal care, obstetric care of pregnant and postpartum women with substance
use disorder, obstetric blood clots and maternal sepsis. The Maternal Safety Consensus Bundle
provides a roadmap for the 4Rs: Readiness, Recognition, Response, and Reporting & Systems
Learning. Systems learning includes health systems-wide provider bias (implicit and explicit
bias) and teamwork training incorporated into the cultures of all clinical and community areas
where birthing parents are being cared for, in addition to raising organizational and individual
provider awareness on cultural humility and competency (Howell et al., 2018; Hughes et al.,
2016). Through sustained regular education of healthcare providers, improving health provider
workforce diversity and holding each other accountable for improving care and health
outcomes for racially and ethnically diverse birthing people, the process to shift the narrative in
racial inequities at large may begin.
Safety bundles have been shown to reduce racial and ethnic related differences in
maternal health outcomes. For instance, a controlled trial of one Quality Improvement (QI)
toolkit in California involving 147 hospitals with over 330,000 births annually showed a
decrease of 20.8% in SMM from hemorrhage (22.7 vs. 18.0 SMMs per 100 hemorrhage cases)
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at intervention hospitals compared with a 1.2% decrease at nonintervention hospitals. Between
2006-2013, overall maternal deaths in the state decreased by 57% (16.9 vs. 7.3 maternal deaths
per 100,000 live births); maternal deaths among non-Hispanic Black women also reduced by
about 50% (51.0 vs. 26.4%) (Main, 2018). AIM has the goal of making every birthing hospital
and facility in the U.S. use these safety bundles to reduce maternal mortality by 50% by 2025.
3.2.4 Doula Support
Access to doula support for pregnant and postpartum Black women has historically also
been limited despite the known benefits, such as lower rates of cesarean delivery, lower rates
of forceps or vacuum deliveries, childbirth education and preparedness, labor support and
advocacy, decreased use of epidural/pain medication in labor, shorter labor hours, fewer
complications, improved birth outcomes, and decreased maternal stress (Kozhimannil et al.,
2014; Thomas et al., 2017). Non-medical doula support in maternity care delivery systems could
improve satisfaction, reinforce positive relationships, and reverse the negative associations
between lack of access to social determinants of health and birth outcomes (Kozhimannil et al.,
2016b). Doula services are not usually covered under currently available traditional health
insurance plans including Medicaid, which contributes to inequities in access due to financial
barriers (Hans, Edwards & Zhang, 2018; Kozhimannil & Hardeman, 2016a). Currently,
Minnesota and Oregon have Medicaid coverage for doula services with clear ethical, equity,
and financial rationale for the policy (Kozhimannil & Hardeman, 2016a). However, there has
been a few bottlenecks in the implementation of the policy with attention required to payment
rates, doula enrollment processes, reimbursement requirements, diversity, and distribution of
workforce (Kozhimannil, Vogelsang & Hardeman, 2015).
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3.2.5 Improved Surveillance and Data Collection
Another factor driving the high rates of SMM and maternal mortality in the U.S. is the
general lack of good and sufficient data for related analysis on maternal and infant health
outcomes. In 2015, only half of the states in the U.S. had MMRCs, and the data collected is not
systematically used to guide changes aimed at reducing maternal morbidity and mortality.
There was no national forum for the states to share either their best practices for reviewing
maternal deaths or the relevant lessons that they may have learned (Agrawal & WHO, 2015).
According to the Commonwealth Fund (2020), it is surprising that maternal mortality data are
missing for about 50% of all U.S. states and territories, and the expectation is that subsequent
annual reports will combine multiple years to enable the comparison of all states (Declercq &
Zephyrin, 2020). A lot of Medicaid and commercial insurance data consist of limited individual
characteristics; race and ethnicity data are sometimes missing in the commercial insurance
data, and similarly, geographic information data is sometimes missing in the Medicaid data
(Chen et al., 2021).
Available evidence shows the prevalence of widespread low-value care among U.S.
residents, leading to unnecessary medical expenses and even harm. State-level policies should
be evaluated to reduce low-value care by mandating medical error reporting and validation,
and use of claims data and electronic health records to measure low-value care (Health Affairs,
2022). The California Maternal Quality Care Collaborative (CMQCC) formed in 2006 to address
rising maternal deaths and complications in the state is a case in point. Formed as a publicprivate partnership to lead maternal quality improvement activities, the CMQCC took steps
over the next 10 years to link public health surveillance to actions: mobilized a wide range of
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public and private partnerships; developed a rapid-cycle Maternal Data Center to support and
sustain quality improvement initiatives; and implements a series of data-driven large-scale
quality improvement programs. Significantly, while the maternal mortality rate in the U.S.
worsened in the 2010s, by 2013 California’s maternal mortality rate was reduced by 50% to a
three-year average of 7.0 maternal deaths per 100,000 live births: comparable to the average
rate of 7.2 per 100,000 live births in Western Europe (Main, Markow & Gould, 2018).
Maternal levels of care and variability in quality of care must be empirically examined.
Research is needed to study the location of childbirth and outcomes of care and the drivers of
variability in quality of care. Attention should focus on differences between rural and urban
contexts in maternal levels of care and variability in obstetric procedure utilization in birthing
facilities (Kozhimannil et al., 2016a; Kozhimannil, Hardeman & Henning-Smith, 2017).

3.2.6 Do Nothing
This means to continue with the status quo which is both unsustainable and not
evidence-based best practice.
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4
4.1

DISCUSSION AND CONCLUSION

Discussion
Data and research drive policy analysis, review, and advocacy. This policy analysis and

review used evidence from the studies of Chen et al. (2021) and Petersen et al. (2019). The
retrospective cohort study of Chen et al. used a sample of 2,667,325 women with delivery
hospitalizations in the U.S. from 2010-2014 and found that SMM developed de novo within 6
weeks after delivery discharge in 14% and 16% of individuals with commercial and Medicaid
insurance coverage, respectively. The study found differences in the factors and maternal
characteristics associated with SMM at delivery and after delivery or discharge: although Black
women, Hispanic women, and women of other races/ethnicities had higher rates of SMM
during delivery hospitalization than White women, it was only the disparity between Black and
White women that persisted into the post-discharge period. Also, residing in the western region
of the U.S. during delivery hospitalization was associated with a higher likelihood of SMM (aOR
1.37) compared with residing in the northeastern region; and residing in the southern region of
the U.S. after delivery hospitalization was associated with a higher likelihood of SMM (aOR
1.29) compared with the northeastern region. The authors concluded that focus on SMM
assessment should be extended to the postdelivery discharge period for opportunities to
improve maternity care.
Peterson et al. used data from CDC’s national Pregnancy Mortality Surveillance System
(PMSS) from 2011–2015 to calculate: PRMRs per 100,000 live births overall and by
sociodemographic characteristics; distribution of pregnancy-related deaths by timing relative to
the end of pregnancy; and leading causes of death. The national PRMR was 17.2 per 100,000
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live births; Black women (42.8) and American Indian/Alaska Native women (32.5) had the
highest PRMRs, 3.3 and 2.5 times higher, respectively, than the PRMR for White women (13.0).
Timing of death was also known in 87.7% of pregnancy related deaths: during pregnancy
(31.3%), on day of childbirth (16.9%), 1-6 days after childbirth (18.6%), 7-42 days after
childbirth (21.4%), and 43-365 days after childbirth (11.7%). The authors also used detailed data
on pregnancy-related deaths between 2013–2017 from 13 state MMRCs to analyze:
preventability and contributing factors to pregnancy-related deaths. The state MMRCs found
that pregnancy-related deaths did not differ significantly by race/ethnicity or timing of death,
and that 60% of these maternal deaths were preventable. The CDC concluded that since
pregnancy-related deaths occurred during pregnancy, around the time of childbirth and up to a
year after childbirth, strategies to address contributing factors to SMM and pregnancy-related
deaths should be multidimensional: at the patient, provider, health facility, community, and
system levels.
Evidence from both studies used in this policy analysis and review shows that access to
good quality healthcare preconception (to treat preexisting conditions), in pregnancy, during
childbirth and up to a year postpartum is imperative to address the high rates of SMM and
pregnancy-related mortality in the U.S. Daw et al. (2017) showed that health insurance
coverage churn experienced by low-income women preconception and in the critical period
after childbirth is one of the drivers of pregnancy-related morbidity and mortality. A systematic
review by Bellerose, Collin & Daw (2022) found that Medicaid expansion through the ACA
improved maternal healthcare access preconception and postpartum with reductions in
uninsurance, insurance churn, private insurance (cost savings), and maternal mortality.
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Medicaid expansion states have had a steady decrease of about 6-7 maternal deaths per
100,000 live births: reduction in maternal deaths was significantly higher among Black women
(16.27) and Hispanic women (6.01) (Eliason, 2020). Medicaid extension will also significantly
increase access of birthing people to health coverage, and support parent and infant health.
Daw et al. (2020) showed that Black, Indigenous, and people of color (BIPOC) experience higher
rates of disruptions in perinatal insurance than White birthing parents. Medicaid extension by
states is permitted by current federal law through a SPA or the 1115 waiver process, however,
SPA has several advantages for states and birthing parents: SPA option provides coverage for
the entire population of birthing people unlike a segment of the population (e.g., substance use
treatment) by waivers; SPA extends coverage to a year postpartum with full benefits unlike
waivers that have varying durations and benefits (e.g., 6 months extension); SPA ensures
consumer protection under federal law (e.g., no cost sharing) unlike waivers without such
protections; SPA would provide federal matching funds for additional expenses incurred by
states unlike waivers that have budget neutrality and states must show that that federal costs
would not be increased; SPA has administrative simplicity and provides parallel two-generation
continuous coverage and eligibility in Medicaid-financed birth for birthing parents and their
infants (APHA, 2021).
Evidence shows the effectiveness of maternal safety bundles in improving safety and
quality of maternal care. Use of safety bundles reduced SMM from hemorrhage (20.8%),
maternal deaths (57%), and racial/ethnic differences in maternal outcomes; maternal deaths
among non-Hispanic Black women also reduced by about 50% (51.0 vs. 26.4%) (Main, 2018).
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The Maternal Safety Consensus Bundle provides standardized evidence-based best practices
and protocols for use in maternity care and obstetric complications and a roadmap for the 4Rs:
Readiness, Recognition, Response, and Reporting & Systems Learning. Systems learning
includes health systems-wide provider bias and teamwork training incorporated into the
cultures of all clinical and community areas where birthing parents are being cared for, in
addition to raising organizational and individual provider awareness on cultural humility and
competency (Howell et al., 2018; Hughes et al., 2016).
Doula support for pregnant and postpartum birthing parents has been shown to: reduce
the rates of cesarean deliveries; reduce the rates of operative vaginal deliveries (forceps or
vacuum); improve childbirth education and preparedness; provide labor support and advocacy
for birthing parents; decrease use of painkillers in labor; reduce birth-related complications;
and improve birth outcomes (Kozhimannil et al., 2014; Thomas et al., 2017). Doula services
should be covered by traditional insurance plans including Medicaid as done currently in
Minnesota and Oregon (Kozhimannil & Hardeman, 2016a).
Improved surveillance and data collection by including race and ethnicity data in
commercial insurance data collection, and geographic location information in all Medicaid data
collection processes. All states should have a rapid-cycle Maternal Data Center to support and
sustain quality improvement initiatives and implement a series of data-driven large-scale
quality improvement programs as was done in California with improved maternal health
outcomes (Main, Markow & Gould, 2018).
Limitations of the studies: The retrospective cohort study of Chen et al. (2021) has some
limitations. First, the Medicaid data was obtained from multiple unknown states in the U.S.
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which may affect the representativeness of the results regarding de novo SMM rates
postdelivery discharge, and geographic and racial disparities. The commercial database used for
the study comprised a convenience sample of the U.S. population. Second, study data had
limited individual characteristics: race and ethnicity are missing in commercial insurance data
while geographic information is missing in Medicaid data. Third, the diagnosis and procedure
codes in administrative databases are recorded for billing and not research purposes. Fourth,
restriction of study sample to individuals with continuous insurance enrollment for at least 6
weeks post hospital discharge reduced sample size by 11% in the Medicaid cohort and 6% in the
commercial insurance cohort which may have biased the estimates of SMM rates by timing of
diagnosis upward or downward.
The Morbidity and Mortality Weekly Report (MMWR) of the CDC by Petersen et al.
(2019) has some limitations. First, errors in reported pregnancy status could lead to
overestimation or underestimation of pregnancy-related deaths. Second, aside from data for
White women and Black women, data for other races or Hispanic origin have inconsistencies of
reporting on death certificates and surveys. Third, pregnancy-relatedness in PMSS for cancerrelated deaths or injury-related deaths like homicides, suicides, or drug overdose have paucity
of information on circumstances of these deaths and is the reason why they are often not
included in PRMR. Fourth, not all preventable deaths according to the MMRCs had a prevention
strategy to address the contributing factors.
Areas for Further Research: Future research should expand focus of SMM assessment to the
post-hospital discharge period for new insights into the burden of post birth morbidity. More
robust data collection on death certificates about the circumstances of maternal death is
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needed because MMRC data found suicides and drug overdoses to be a leading predisposing
cause of pregnancy-related mortality (Zaharatos et al., 2018) and a comprehensive review of all
pregnancy-related deaths can lead to identification of the contributing factors and
implementation of strategies to prevent future events.
4.2

Conclusion
Evidence shows that over half of the cases of SMM and pregnancy-related
mortality in the U.S. are preventable. A key component of quality is having access to the
appropriate care at the right time, especially by low-income Black, Indigenous and people
of color (BIPOC). Although access and quality are two important ways clinicians can
reduce or prevent SMM and maternal mortality, other factors affect the need for, access
to, quality and outcomes of maternity care. Medicaid expansion ensures that all
individuals in a state at or below 138 FPL have access to preventive care and management
of any preexisting health conditions that may cause complications in pregnancy, during
childbirth, and for varying periods postpartum. Medicaid coverage extension postpartum
for one year is imperative as evidence shows that 11.7% of pregnancy-related deaths
occur between 43-365 days after childbirth. Medicaid postpartum extension through SPA
in the ARP rather than Medicaid extension waiver 1115 is preferrable because it offers
birthing parents and their infants a parallel pathway for dual continuous coverage with
full benefits for a year after childbirth, with no copays, ease of application for states, and
federal matching funds for additional expenses incurred by states without budget
neutrality. The maternal safety bundles are evidence-based best practices and protocols
that should be standardized for use in maternity care and obstetric complications in
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hospital and outpatient settings nationwide. Evidence shows that it reduced hemorrhage
related SMM by 20.8%, maternal deaths by 57% and Black maternal deaths by 50%. The
Maternal Safety Consensus Bundle provides a roadmap for the 4Rs: Readiness,
Recognition, Response, and Reporting & Systems Learning. Systems learning includes
health systems-wide provider bias and teamwork training. Doula support in pregnancy,
during childbirth and the postpartum period has been shown to reduce the rates of
cesarean section, use of analgesia in labor, poor maternal and infant outcomes, especially
among BIPOC. There should be Medicaid coverage for doula services nationwide as
currently practiced in Minnesota and Oregon. There should be federal and state policies
on improved surveillance and data collection for maternity care. Rapid-cycle Maternal
Data Center should be developed to support and sustain quality improvement initiatives
for maternity services nationwide with implementation of data-driven quality
improvement programs. Policies should mandate medical error reporting and validation,
and use of claims data and electronic health records to measure low-value care.
In conclusion, to reduce the huge annual cost of childbirth and newborns in the
U.S. estimated at over $10 billion, improvement in healthcare access and provision of
evidence-based interventions to birthing people preconception, in pregnancy, during
childbirth, and postpartum is imperative to reduce the high rates of adverse maternal and
infant outcomes.
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APPENDICES
Appendix A
Key Terms and Definitions
Maternal Mortality: Deaths during pregnancy and up to 42 days after childbirth that are from
causes related to pregnancy. This definition is used by the World Health Organization (WHO) for
international comparisons and reported as a ratio per 100,000 live births.
Pregnancy-Related Mortality: Deaths during pregnancy and up to one year after childbirth that
are from causes related to pregnancy. This definition is used by the Centers for Disease Control
and Prevention (CDC) to report trends in the U.S. per 100,000 live births.
Pregnancy-Associated Mortality: Deaths during pregnancy and up to one year after childbirth,
irrespective of cause.
Preventable Death: A death is considered preventable if the Maternal Mortality Review Committee
determines that there was some chance of the death being averted by one or more reasonable
changes to patient, community, provider, health facility, and/or system factors.
Severe Maternal Morbidity: Unexpected outcomes of labor and delivery that result in significant
short- or long-term consequences to a woman’s health. It could be a life-threatening diagnosis
or a lifesaving procedure.
Birthing People/Parent: Women and individuals who are pregnant, and those who give birth to
a child. This is an inclusive term in recognition that not all individuals who become pregnant
and give birth identify as women.
Sources: Birthing People/Parent (O'Neil et al., 2021); Maternal Mortality, Pregnancy-Associated
Mortality, Pregnancy-Related Mortality (Commonwealth Fund, 2020); Severe Maternal
Morbidity (Kilpatrick, Ecker, J. L., & ACOG, 2016); Preventable Death (Petersen et al., 2019).
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